95 results
Page 2 of 5
6-K
EX-99.1
1qwtikd2gpgc1cm
16 Nov 23
Not for release to US wire services or distribution in the United States
9:38am
6-K
EX-99.2
x5up1
16 Nov 23
Not for release to US wire services or distribution in the United States
9:38am
6-K
EX-99.1
d5b2eomqwam81jv
8 Nov 23
Results of Scheme Meetings
6:07am
6-K
EX-99.1
ku1efm8s67fp55ghmnjg
18 Oct 23
Voting Update for Incannex to Redomicile to United States and Trade on Nasdaq Securities Exchange
7:09pm
6-K
EX-99.1
msaetnv1me
8 Sep 23
Report of Foreign Private Issuer
6:03am
6-K
EX-99.1
shexda8v1nl
1 Sep 23
Report of Foreign Private Issuer
12:00am
6-K
EX-99.1
rl3np6x2ldk
23 Aug 23
Report of Foreign Private Issuer
7:47pm
6-K
EX-99.1
5yb7gv5ikwp2r3ykjc
22 Aug 23
Review of IND Application for IHL-42X by US FDA has been completed; Clinical Trial for Patients with Obstructive Sleep Apnoea May Proceed
6:01am
6-K
EX-99.1
m5ndyz iur
10 Aug 23
Report of Foreign Private Issuer
6:03am
6-K
EX-99.1
sc09ojtfsx0x nt4vjl
8 Aug 23
Clarion Clinics Begins Accepting Registrations for Psychedelic Treatment Interest as Part of Pre-Screening in Readiness for Opening
6:02am
6-K
EX-99.1
mdc55k
31 Jul 23
Incannex Provides Access to Financial Advisory Firm to Shareholders for Advice Pertaining to Transition from ASX to Nasdaq
7:34pm
6-K
EX-99.1
9dkzs5jqt7nn4m518y2
25 Jul 23
Incannex Completes Positive Pre-IND Meeting with US FDA on IHL-675A for Treatment of Rheumatoid Arthritis
9:42pm
6-K
EX-99.1
b7x710
20 Jul 23
Incannex Submits IND Application to the US FDA for IHL-42X for Obstructive Sleep Apnoea
9:47pm
6-K
EX-99.1
nj1cc5la v7tm
18 Jul 23
Incannex engages Fortrea to Manage its FDA IND Opening Phase 2/3 Clinical Trial Investigating IHL-42X for Treatment of Obstructive Sleep Apnoea
6:04am
6-K
EX-99.1
deqye0p3d
13 Jul 23
Incannex Receives HREC Approval for Phase 2 Clinical Trial Assessing IHL-675A for use in Treatment of Pain and Function in Rheumatoid Arthritis
6:02am
6-K
EX-99.1
8tt2wj
10 Jul 23
Incannex Announces Intention to Redomicile to United States, List all Shares on Nasdaq
8:43am
6-K
EX-99.1
oot6yaw a1ekceod7p
5 Jul 23
Report of Foreign Private Issuer
8:47pm
6-K
EX-99.1
en4708 aav35ekg
22 Jun 23
Incannex Announces Participation at the H.C. Wainwright 4th Annual Neuropsychiatry Virtual Conference
8:05pm
6-K
EX-99.1
i03tsl
15 Jun 23
Incannex Appoints Principal Investigators for IHL-42X Phase 2/3 Clinical Trial
9:06pm